Document is current
Any future updates will be listed below
-
Authors
,
Scheijen, Blanca
Meijers, Ruud W. J.
Rijntjes, Jos
van der Klift, Michèle Y.
Möbs, Markus https://orcid.org/0000-0002-1502-3032
Steinhilber, Julia
Reigl, Tomas
van den Brand, Michiel
Kotrová, Michaela https://orcid.org/0000-0001-5394-1072
Ritter, Julia-Marie
Catherwood, Mark A.
Stamatopoulos, Kostas
Brüggemann, Monika
Davi, Frédéric
Darzentas, Nikos
Pott, Christiane
Fend, Falko
Hummel, Michael
Langerak, Anton W.
Groenen, Patricia J. T. A.
- License Information
-
More Information
Article History
Received: 15 January 2019
Revised: 25 March 2019
Accepted: 26 April 2019
First Online: 13 June 2019
Compliance with ethical standards
:
: The EuroClonality-NGS Working Group is an independent scientific subdivision of EuroClonality that aims at innovation, standardization, and education in the field of diagnostic clonality analysis. The revenues of the previously obtained patent (PCT/NL2003/000690), which is collectively owned by the EuroClonality Foundation and licensed to InVivoScribe, are exclusively used for EuroClonality activities, such as for covering costs of the Working Group meetings, collective WorkPackages, and the EuroClonality Educational Workshops. MvdB: speaker for Gilead. KS: research support from Janssen, Abbvie, Gilead; speaker for Janssen, Abbvie, Gilead; advisory board for Janssen, Abbvie, Gilead. MB: contract research for Affimed, Amgen, Regeneron; advisory board for Amgen, Incyte; speaker for Janssen, Pfizer, Roche. FF: advisory board for Roche, speaker for Janssen, Takeda. AWL: contract research for Roche-Genentech; research support from Gilead; advisory board for Abbvie; speaker for Gilead, Janssen. PJTAG: speaker for Gilead. The remaining authors declare that they have no conflict of interest.
